Podcasts

DPP-4 Antagonists: Benefits, Risks, and the Future

Dipeptidyl peptidase-4 inhibitors, of the incretin class of antidiabetes drugs, are weight neutral, avoid hypoglycemia, and result in an average reduction in HbA1c of 0.5% to 1.0%

USPSTF: Increase HIV Detection through Routine Screening

Approximately 25% of those infected with HIV are unaware of their positive status. The USPSTF says universal screening can help reduce disease burden.

Helping Freedom Be as Good as Prison for Ex-Inmates With HIV

(AUDIO) Correctional institutions offer an excellent opportunity to discover and treat HIV infection, which is usually contracted before incarceration. How can physicians assure that care is just as good after these patients are released into the community?

Common Side Effects of Antiretroviral Therapy in HIV Infection

What are some of the more common side effects of antiretroviral therapy, and what can the primary care physician do to help manage these effects? In this podcast, infectious disease expert Rodger MacArthur, MD, offers insights and points readers to updated comprehensive guidelines.

Hepatic Encephalopathy: Will You Recognize It in Its Very Early Stages?

What are first signs and symptoms of hepatic encephalopathy? When should you start treating-at the first episode? How to measure ammonia levels? When to send the patient for transplant evaluation?

Clinical Tips for Using Antibiotics and Corticosteroids in IBD

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

Extraintestinal Manifestations of Inflammatory Bowel Disease: Common and Manageable

Extraintestinal manifestations of inflammatory bowel disease affect the musculoskeletal, dermatologic, ocular, renal and pulmonary systems.

The Great Beta-Blocker Debate: The Pros and Cons

Newly diagnosed hypertension in a patient whose blood pressure is 152/94 mm Hg. What agents will you consider for this patient? Beta-blockers? Think again.

HIV Advances Prompt Reanalysis of USPSTF Screening Policies

(AUDIO) US Preventive Services Task Force recommendations for HIV screening may come into line with CDC guidelines thanks to a reanalysis of recent outcomes data. Here clinical epidemiologist Roger Chou MD, who conducted the analysis, describes the new evidence and the implications.

Lipid-lowering Injectable Antibodies: The Next Big Thing?

PCSK-9 inhibition in patients with recalcitrant hypercholesterolemia has reaped reductions in LDL-C of up to 85% after the first week of therapy.